Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription
- 15 May 2018
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 92 (10)
Abstract
Cytidine deaminases inhibit replication of a broad range of DNA viruses by deaminating cytidines on single-stranded DNA (ssDNA) to generate uracil. While several lines of evidence have revealed hepatitis B virus (HBV) genome editing by deamination, it is still unclear which nucleic acid intermediate of HBV is modified. Hepatitis B virus has a relaxed circular double-stranded DNA (rcDNA) genome that is reverse transcribed within virus cores from a RNA template. The HBV genome also persists as covalently closed circular DNA (cccDNA) in the nucleus of an infected cell. In the present study, we found that in HBV-producing HepAD38 and HepG2.2.15 cell lines, endogenous cytidine deaminases edited 10 to 25% of HBV rcDNA genomes, asymmetrically with almost all mutations on the 5′ half of the minus strand. This region corresponds to the last half of the minus strand to be protected by plus-strand synthesis. Within this half of the genome, the number of mutations peaks in the middle. Overexpressed APOBEC3A and APOBEC3G could be packaged in HBV capsids but did not change the amount or distribution of mutations. We found no deamination on pregenomic RNA (pgRNA), indicating that an intact genome is encapsidated and deaminated during or after reverse transcription. The deamination pattern suggests a model of rcDNA synthesis in which pgRNA and then newly synthesized minus-sense single-stranded DNA are protected from deaminase by interaction with the virus capsid; during plus-strand synthesis, when enough dsDNA has been synthesized to displace the remaining minus strand from the capsid surface, the single-stranded DNA becomes deaminase sensitive. IMPORTANCE Host-induced mutation of the HBV genome by APOBEC proteins may be a path to clearing the virus. We examined cytidine-to-thymidine mutations in the genomes of HBV particles grown in the presence or absence of overexpressed APOBEC proteins. We found that genomes were subjected to deamination activity during reverse transcription, which takes place within the virus capsid. These observations provide a direct insight into the mechanics of reverse transcription, suggesting that newly synthesized dsDNA displaces ssDNA from the capsid walls, making the ssDNA accessible to deaminase activity.Keywords
Funding Information
- Assembly Biosciences (Supported Research)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R56-AI077688)
This publication has 73 references indexed in Scilit:
- Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review)Molecular Medicine Reports, 2015
- Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseasesNature Reviews Drug Discovery, 2013
- Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deaminationCell Cycle, 2013
- Methylcytosine and Normal Cytosine Deamination by the Foreign DNA Restriction Enzyme APOBEC3AJournal of Biological Chemistry, 2012
- New perspectives in the therapy of chronic hepatitis BGut, 2012
- Massive APOBEC3 Editing of Hepatitis B Viral DNA in CirrhosisPLOS Pathogens, 2010
- Conserved Footprints of APOBEC3G on Hypermutated Human Immunodeficiency Virus Type 1 and Human Endogenous Retrovirus HERV-K(HML2) SequencesJournal of Virology, 2008
- The conformation of double-stranded DNA inside bacteriophages depends on capsid size and shapeJournal of Structural Biology, 2007
- Complementarity between epsilon and phi sequences in pregenomic RNA influences hepatitis B virus replication efficiencyVirology, 2007
- High expression of APOBEC3G in patients infected with hepatitis C virusJournal of Molecular Histology, 2006